people with diabetes announced that safety and performance data from its first-in-human trial of its long-term continuous blood glucose ...
Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...
(RTTNews) - Glucotrack, Inc. (GCTK), Wednesday, announced the results from its first-in-human trial of its continuous blood glucose monitoring or CBGM system, which will be presented at the 2025 ...
Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with ...
GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company’s ...
Copyright © 2025 MarketWatch, Inc. All rights reserved.
After hours: March 17 at 7:32:07 p.m. EDT Loading Chart for GCTK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback